Everything we do is designed around safer Tirzepatide treatment, from assessment and dose progression to cold-chain delivery and side-effect support.
Tirzepatide is an injectable medication originally developed for Type 2 diabetes that has also been shown to produce significant weight loss in clinical trials.
These medications work by mimicking natural hormones that regulate appetite, blood sugar, and digestion. They have been extensively studied in large-scale clinical trials involving tens of thousands of participants.
GLP-1 medications act on receptors in the brain that control hunger and satiety, reducing appetite and food cravings. Patients typically experience a natural reduction in caloric intake without feeling deprived.
These medications slow the rate at which food leaves the stomach, helping you feel full longer after meals. This contributes to reduced portion sizes and more mindful eating patterns.
The SURMOUNT clinical trial programme showed that tirzepatide produced up to 22.5% body weight reduction over 72 weeks. These are among the most effective weight treatments ever studied.
Like all medications, GLP-1 receptor agonists may cause side effects. Most are mild to moderate and tend to improve as your body adjusts, especially during the initial titration period.
These affect a significant proportion of patients, typically during the first few weeks. They usually improve with time and dose adjustment.
These are uncommon but require immediate medical attention. Contact us or go to your nearest hospital if you experience any of these.
If you experience severe abdominal pain, persistent vomiting, difficulty breathing, swelling of the face or throat, or any symptoms that feel like an emergency, stop your medication and seek immediate medical attention. Contact Second Cure support and call 112 or go to your nearest hospital.
Safety is not a feature of our service. It is the foundation of everything we do.
Every order starts with an assessment that screens for contraindications, medication interactions, BMI fit, and previous GLP-1 experience.
Tirzepatide should be handled cold. Our delivery flow is built around refrigerated handling from dispatch to drop-off.
New patients start low. Higher doses stay gated until the lower-dose path has been completed and reviewed.
Reported side effects and missed check-ins are surfaced quickly so the right follow-up can happen before small issues become bigger ones.
Tirzepatide is not suitable for everyone. The following conditions are major stop signs or reasons for extra review before treatment moves forward.
GLP-1 medications are not approved for use during pregnancy or breastfeeding. You must stop treatment at least 2 months before a planned pregnancy.
GLP-1 receptor agonists are not indicated for Type 1 diabetes and may cause dangerous hypoglycaemia when combined with insulin in this population.
Patients with a personal history of pancreatitis should not use GLP-1 medications due to the potential risk of recurrence.
GLP-1 medications are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2).
Patients with active anorexia nervosa, bulimia, or binge eating disorder require specialist psychiatric and nutritional support before considering GLP-1 treatment.
Patients with gastroparesis or severe inflammatory bowel disease may experience worsened symptoms with GLP-1 medications.
While severe side effects are rare, it is important to know what to do. Your safety is our first priority.
If you believe you are experiencing a medical emergency, do not wait for a response from Second Cure. Call 112 or go to your nearest hospital immediately.
Stop your medication immediately if you experience severe symptoms such as intense abdominal pain, difficulty breathing, or severe allergic reaction.
Call 112 or go to your nearest hospital emergency department if symptoms are severe or life-threatening.
Contact Second Cure through your account support channel once you are safe so the event can be recorded and followed up.
Keep your medication and packaging for reference. Bring it with you if you go to hospital so the treating team can see the exact product and batch.
Our assessment screens for contraindications and helps make sure Tirzepatide starts at the right point for you.